SLK-Kliniken Heilbronn GmbH — Clinical Trial Site

91 Registered trials

40 Currently recruiting

Organisation

SLK-Kliniken Heilbronn GmbH

Location

Heilbronn, Germany

Identifier

ORG-100018114

Address

Geisshoelzle 62, Hirrweiler, 74245, Germany

Departments

2605 : Standort Fachklinik Löwenstein, Med.Klinik II Onkologie mit Palliativmedizin
2612: Standort Fachklinik Löwenstein, Med.Klinik II Onkologie mit Palliativmedizin
Brustzentrum
Clinic for Internal Medicine III
Clinic of Internal Medicine III
Department of Gynecology and obstetrics
Department of Internal Medicine III
Fachklinik Loewenstein
Fachklinik Löwenstein
Fachklinik Löwenstein, Med. Klinik I, Pneumologie
Frauenklinik
Frauenklinik / Brustzentrum
Gynecology
Heilbronn SLK-Kliniken
Hematology
Hematology/Oncology
Innere Medizin III, Schwerpunkt Häma./Onko./Palliativm.
Kardiologie
Kardiologie, Angiologie und Intensivmedizin
KIinik für Thorakale Onkologie und Palliativmedizin
Kinder- und Jugendmedizin mit Perinatalzentrum
Klinik fuer Innere Medizin III
Klinik für Frauenheilkunde und Geburtshilfe
Klinik für Gynäkologie und Geburtshilfe
Klinik für Innere Medinzin III
Klinik für Innere Medizin I: Kardiologie, Angiologie und Intensivmedizin
Klinik für Innere Medizin III
Klinik für Innere Medizin III Hämatologie, Onkologie, Palliativmedizin Klinik am Gesundbrunnen
Klinik für Innere Medizin III, Onkologisches Studienzentrum
Klinik für Innere Medizin III:Hämatologie, Onkologie und Pall
Klinik für Innere Medizin, III Klinikum am Gesundbrunnen
Klinik für Kardiologie, Angiologie und Intensivmedizin
Klinik für Kinder- Jugendmedizin
Klinik für Pneumologie, Intensiv- und Beatmungsmedizin
Klinik für Thorakale Onkologie
Klinik für Thorakale Onkologie und Palliativmedizin
Klinik für Urologie und Kinderurologie
Klinik Löwenstein, Klinik fuer Pneumologie, Intensiv- und Beatmungsmedizin
Klinikum am Gesundbrunnen
Klinikum am Gesundbrunnen Klinik für Innere Medizin III
Klinikum am Gesundbrunnen / Frauenklinik
Klinikum am Plattenwald
Med. Klinik II Onkologie
Med. Klinik II Onkologie mit Palliativmedizin
Med. Klinik II, Onkologie
Med.Klinik II Onkologie
Medizinische Klinik II Oncology
Medizinische Klinik II Onkologie / Krebsheilkunde mit Palliativmedizin
Medizinische Klinik II, Onkologie
Medizinische Klinik III
N/A
Pediatric and adolescent medicine
Pediatric Hematology/Oncology
SLK Kliniken Heilbronn - Klinik für Gynäkologie und Geburtshilfe
SLK-Kliniken - Fachklinik Löwenstein
SLK-Kliniken Heilbronn GmbH
Standort Fachklinik Loewenstein, Klinik fuer Thorakale Onkologie und Palliativmedizin
Standort Fachklinik Löwenstein Med.Klinik II Onkologie
Thoracic Oncology Department

Clinical trials at this site (91)

Search interface

Study of Intravenous Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor to Assess Adverse Events and Change in … Recruiting

2024-514465-18-00 Advanced or Metastatic Non-Squamous NSCLC 9 2025-04-23
SURVIVE HERoes – A randomized Secondary Adjuvant Treatment Intervention study comparing Trastuzumab-Deruxtecan to SOC therapy in eBC Patient… Recruiting

2024-516173-76-01 HER2-positive or HER2-low (incl. ultra-low) early breas 5 2025-04-22
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Recruiting

2023-504904-26-00 Progressive Pulmonary Fibrosis 5 2025-04-07
Pan-tumor Study of I-DXd in Subjects with Recurrent or Metastatic Solid Tumors Recruiting

2023-509632-26-00 Recurrent or Metastatic Solid Tumors (endometrial cance 9 2025-02-11
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Recruiting

2023-509706-30-00 Heart failure (HF) 5 2024-10-18
NeoAdjuvant study comparing sacituzumab govitecan versus sacituzumab govitecan+pembrolizumab treatment in low-risk, triple-negative early br… Recruiting

2023-508787-29-00 Triple-negative early breast cancer with low risk for r 4 2024-10-10
N-PLUS Recruiting

2022-502559-69-01 advanced (FIGO stage IIIA, IIIB, IIIC, or IV of the 201 4 2024-07-04
A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults wi… Recruiting

2022-501187-18-00 a. Diffuse large B-cell lymphoma (DLBCL) not otherwise 5 2023-04-24
International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents Recruiting

2022-500783-35-00 Acute Myeloid Leukemia 5 2022-12-06
CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCE… Recruiting

2022-500764-35-00 Patients with advanced HER2-negative, hormone receptor 6 2022-10-13
Inhalation therapy in adult bronchiectasis patients with new asymptomatic Pseudomonas aeruginosa infection– an open-label, proof of concept … Recruiting

2023-509277-22-00 Bronchiectasis 4 2022-06-22
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Patients With Stage III Unresectabl… Recruiting

2023-506891-28-00 The target population of interest in this study is part 5 2022-05-02
Intrathecal application of PD-1 antibody in metastatic solid tumors with leptomeningeal disease Recruiting

2024-514068-14-00 leptomeningeal disease 9 2021-10-12
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (INTRINSIC) Recruiting

2023-505163-37-00 Metastatic Colorectal Cancer 3 2021-10-01
Phase 2 Study of Adagrasib Monotherapy and in Combination With Pembrolizumab and Phase 3 Study of Adagrasib in Combination with Pembrolizuma… Recruiting

2023-508922-83-00 Advanced Non-Small Cell Lung Cancer 10 2021-03-17
A First-in-Human Study to Evaluate the Safety and Anti-cancer Activity of the product FS222, which is an Antibody medication, in Subjects wi… Recruiting

2024-514010-12-00 Advanced Malignancies 1 2020-12-03
Pan tumor Roll Over Study Recruiting

2023-506914-32-00 Pan tumor 4 2020-05-05
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
A study of the PAN-KRAS inhibitor LY4066434 in participants with KRAS mutant solid tumors. Ended

2024-516733-12-00 Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung C 1 2025-05-13
A trial to learn how well AZD0901 works and how safe it is compared to standard cancer treatments in adults with advanced and metastatic gas… Ended

2023-508276-11-00 Gastric cancer, Advanced/Metastatic Gastric cancer, Gas 5 2025-01-17
A phase 1/2 multiple-indication biomarker, safety, and efficacy study in advanced or metastatic Gastrointestinal cancers exploring treatment… Ended

2024-515936-62-00 Patients with advanced or metastatic gastrointestinal ( 9 2024-10-10
A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD L1 high NSCLC Ended

2023-504753-12-00 Lung Cancer, Non-Small Cell 5 2024-10-01
A Study of Lepodisiran (LY3819469) in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Ended

2023-509190-23-00 Atherosclerotic Cardiovascular Disease Elevated lp(a) 5 2024-09-03
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients with previously treated KRAS G12C-positive… Ended

2024-510908-37-00 KRAS G12C-Positive Advanced or Metastatic Non-Small Cel 5 2024-08-28